These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 15067512

  • 1. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M, Koike H, Han GD, Shimizu F, Kawachi H.
    Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
    [Abstract] [Full Text] [Related]

  • 2. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
    Ding HL, Guo Y, Xu MT, Li HY, Fu ZZ.
    Chin Med J (Engl); 2007 Nov 05; 120(21):1886-9. PubMed ID: 18067760
    [Abstract] [Full Text] [Related]

  • 3. Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.
    Jacot TA, Striker GE, Stetler-Stevenson M, Striker LJ.
    Lab Invest; 1996 Dec 05; 75(6):791-9. PubMed ID: 8973474
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.
    Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT.
    Lab Invest; 1998 Sep 05; 78(9):1077-87. PubMed ID: 9759652
    [Abstract] [Full Text] [Related]

  • 5. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283
    [Abstract] [Full Text] [Related]

  • 6. Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats.
    Kuroda T, Yoshida Y, Kamiie J, Kovalenko P, Nameta M, Fujinaka H, Yaoita E, Endo T, Ishizuka S, Nakabayashi K, Yamada A, Nagasawa T, Yamamoto T.
    Clin Exp Nephrol; 2004 Sep 02; 8(3):206-15. PubMed ID: 15480897
    [Abstract] [Full Text] [Related]

  • 7. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
    Li Q, Zhou X, Yu J, Qian W, Xu KS.
    Zhonghua Yi Xue Za Zhi; 2008 May 13; 88(18):1273-8. PubMed ID: 18844103
    [Abstract] [Full Text] [Related]

  • 8. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J, Windsor LJ.
    J Periodontal Res; 2006 Feb 13; 41(1):47-54. PubMed ID: 16409255
    [Abstract] [Full Text] [Related]

  • 9. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R.
    J Pharmacol Exp Ther; 2006 Jan 13; 316(1):8-16. PubMed ID: 16166267
    [Abstract] [Full Text] [Related]

  • 10. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
    McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, Gilbert RE.
    Diabetologia; 2002 Feb 13; 45(2):268-75. PubMed ID: 11935159
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb 13; 27(1):53-61. PubMed ID: 15782494
    [Abstract] [Full Text] [Related]

  • 12. Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis.
    Mitani O, Katoh M, Shigematsu H.
    Pathol Int; 2004 Apr 13; 54(4):241-50. PubMed ID: 15028025
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.
    Am J Hypertens; 2004 Sep 13; 17(9):775-82. PubMed ID: 15363819
    [Abstract] [Full Text] [Related]

  • 14. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
    Inaki N, Tsunezuka Y, Kawakami K, Sato H, Takino T, Oda M, Watanabe G.
    J Heart Lung Transplant; 2004 Feb 13; 23(2):218-27. PubMed ID: 14761770
    [Abstract] [Full Text] [Related]

  • 15. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB, Li DG, Lu HM.
    J Gene Med; 2007 Mar 13; 9(3):217-29. PubMed ID: 17351970
    [Abstract] [Full Text] [Related]

  • 16. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
    Ottino P, He J, Axelrad TW, Bazan HE.
    Invest Ophthalmol Vis Sci; 2005 Feb 13; 46(2):487-96. PubMed ID: 15671273
    [Abstract] [Full Text] [Related]

  • 17. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhonghua Yi Xue Za Zhi; 2004 Aug 02; 84(15):1288-93. PubMed ID: 15387968
    [Abstract] [Full Text] [Related]

  • 18. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep 02; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 19. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P, Kwon YJ, Alliende C, Leyton L, Aguilera S, Molina C, Labra C, Julio M, Leyton C, González MJ.
    Arthritis Rheum; 2005 Sep 02; 52(9):2751-60. PubMed ID: 16142742
    [Abstract] [Full Text] [Related]

  • 20. Macrophage-derived MT1-MMP and increased MMP-2 activity are associated with glomerular damage in crescentic glomerulonephritis.
    Hayashi K, Horikoshi S, Osada S, Shofuda K, Shirato I, Tomino Y.
    J Pathol; 2000 Jul 02; 191(3):299-305. PubMed ID: 10878552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.